• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OLYMPUS MEDICAL SYSTEMS CORP. SNARE WIRE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OLYMPUS MEDICAL SYSTEMS CORP. SNARE WIRE Back to Search Results
Model Number MAJ-11
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hemorrhage/Bleeding (1888); Perforation (2001)
Event Type  Injury  
Event Description
Olympus reviewed the following literature "utility of underwater emr for nonpolypoid superficial nonampullary duodenal epithelial tumors =20 mm."     literature summary.This retrospective study analyzed the utility of underwater endoscopic mucosal resection for nonpolypoid superficial non-ampullary duodenal epithelial tumors =20 mm.A total of 132 patients (emr 21 patients 23 snadet, uemr 60 patients 61 snadet, emrc 45 patients 48 snadet) were included.For endoscopic resection, upper endoscope (gif q240z, gif q260j, gif h260z, or gif-h290t; olympus ) was used.For emr and emrc, saline and/or 10% glycerin solution (glyceol; chugai pharmaceutical ) with indigo carmine was administered for submucosal injection.For snaring of emr and uemr, a 10- to 20-mm electrocautery snare (maj-11, maj-216, snaremaster; olympus or captivator; boston scientific) was used.In emrc, a transparent cap (maj-291 or maj-296; olympus ) with an outer diameter of 14.8 or 16.1 mm was attached to the tip of the endoscope.A half moon braided snare (sd-7p-1; olympus) was used for snaring.Both uemr and emrc had a significantly higher r0 resection rate than emr.Uemr had significantly lower multiple resection and post-bleeding rates than emr.In terms of adverse events, only one (2.1%) patient who underwent emrc presented with intraoperative and postoperative perforation.Postoperative bleeding was defined as overt hematemesis, or a decreased hemoglobin concentration >2 g/dl after the procedure.Emr was involved in rx/1 and piecemeal resection.The recurrence rates of emr, uemr, and emrc were 4.3%, 2.0%, and 6.3%, respectively.This study concluded that the uemr had significantly higher r0 resection and lower post-bleeding rates than emr.Moreover, it was safer than emrc and was associated with a lower incidence of recurrences.The significant results of the retrospective analysis suggest a randomized controlled study with adequate numbers need to be conducted to confirm the superior efficacy of uemr before it is recommended for primary treatment option for snadet measuring =20 mm.The author responded to a request for additional information stating the adverse events were not caused by the olympus devices.Type of adverse events/number of patients endoscopic mucosal resection (emr): postoperative bleeding - 2 patients.Underwater emr (uemr): postoperative bleeding - 1 patient.Cap-assisted emr (emrc): postoperative bleeding - 1 patient.Intraoperative perforation - 1 patient.Delayed perforation - 1 patient.  this article includes 7 reports: patient identifier (b)(6):gif-q240z.Patient identifier (b)(6):gif-q260j or gif-h260z.Patient identifier (b)(6):gif-h290t.Patient identifier (b)(6):maj-11.Patient identifier (b)(6): maj-291 or maj-296.Patient identifier (b)(6): sd-7p-1.Patient identifier (b)(6): maj-216 wire.This report is 4 of 7 for patient identifier (b)(6):maj-11.
 
Manufacturer Narrative
The suspect device has not been returned to olympus for evaluation.The legal manufacturer's investigation is complete.The device history records (dhr) for this device could not be reviewed since the serial number was not provided.Olympus ships devices manufactured according to all applicable procedures and meet final product release criteria.A definitive root cause was not identified.Based on the available information, the legal manufacturer was unable to determine the probable cause of the adverse events since the device was not returned for evaluation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SNARE WIRE
Type of Device
WIRE
Manufacturer (Section D)
OLYMPUS MEDICAL SYSTEMS CORP.
2951 ishikawa-cho
hachioji-shi, tokyo-to 192-8 507
JA  192-8507
Manufacturer Contact
kazutaka matsumoto
2951 ishikawa-cho
hachioji-shi, tokyo-to 192-8-507
JA   192-8507
426425177
MDR Report Key14717114
MDR Text Key294619004
Report Number8010047-2022-10186
Device Sequence Number1
Product Code FAS
UDI-Device Identifier04953170035999
UDI-Public04953170035999
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K955650
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 06/16/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/16/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberMAJ-11
Device Lot NumberUNKNOWN(LITERATURE)
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received05/18/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
UNKNOWN LOT: MAJ-291, SD-7P-1, MAJ-216; UNKNOWN SERIAL: GIF-Q240Z, GIF-Q260J, GIF-H290T
Patient Outcome(s) Other;
-
-